Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_assertion type Assertion NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_head.
- NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_assertion wasGeneratedBy ECO_0000203 NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_provenance.
- NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_assertion wasDerivedFrom befree-20150227 NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_provenance.
- NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_assertion SIO_000772 21815696 NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_provenance.
- NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_assertion evidence source_evidence_literature NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_provenance.
- NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_assertion description "[The success of immune therapy with the anti-cytotoxic T-lymphocyte antigen-4 antibody ipilimumab in advanced melanoma has spurred interest in the development of vaccines and immune therapies for other solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451788.RA3-m2RP_lVngWvyw-xMpYdFhviapNKt3RXb1TLJ8btdE130_provenance.